Home/ Supplements/ Lysine/ L-Lysine 1000 mg

L-Lysine 1000 mg

product on market Tablet or Pill 21st Century Safety: 100/100
100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • Limited research evidence available for ingredients
B Label Compliance Grade
Label

Product Label

Label for L-Lysine 1000 mg
Open Full PDF View on NIH DSLD →
Details

Label Data

1 Tablet(s)
Serving Size
90
Servings
Amino acid/Protein
Product Type
0%
Evidence Coverage
Ingredients

Supplement Facts — Evidence Check

1000 mg
Market median: 500.0mg (159 products)

Other Ingredients

Cellulose Stearic Acid Croscarmellose Sodium Magnesium Silicate Magnesium Stearate Polyethylene Glycol Polyvinyl Alcohol Silicon Dioxide Titanium Dioxide
Claims

Label Claims — Verification

Unverified Nutrient
Unverified All Other
Unverified Structure/Function
Info

Product Information

Directions for Use

Directions: As a dietary supplement, adults take one (1) tablets daily with any meal or as directed by a healthcare provider.

Warnings & Precautions

Do not exceed recommended dosage. Individual results may vary.

Warning: Consult a healthcare provider prior to use if pregnant, nursing, on medications, have a medical condition or are planning a medical procedure.

Stop use and contact a physician if adverse reactions occur. Do not use if product appears to be tampered with or seal is broken.

Keep out of reach of children.

Formulation Notes

L-Lysine is an essential amino acid which must be supplied rom nutritional sources and is a building block of protein.

No added sugar, yeast, preservatives or artificial flavors.

Suitable for vegans.

Actual size

Skin & tissue support

Gluten free Non-GMO

Guaranteed quality Laboratory tested Trusted quality for over 30 years

Additional Information

Store at room temperature.

Metadata

Product Details

UPC / SKU7 40985 28063 8
DSLD Entry Date2024-01-24
Product TypeAmino acid/Protein
FormTablet or Pill
DSLD ID304110
Data Updated2026-04-11
Research

Research Evidence

3
Research Sources
74
Avg Quality
3
Meta Analysis
A Antifibrinolytics (lysine analogues) for the prevention of bleeding in people with haematological disorders
Meta Analysis The Cochrane database of systematic reviews 2026 PubMed DOI
B Antifibrinolytics (lysine analogues) for the prevention of bleeding in people with haematological disorders
Meta Analysis The Cochrane database of systematic reviews 2016 PubMed DOI
B Antifibrinolytics (lysine analogues) for the prevention of bleeding in patients with haematological disorders
Meta Analysis The Cochrane database of systematic reviews 2013 PubMed DOI
View all evidence for Lysine →
Compare

Similar Products

View all Lysine products →

This product page is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before taking any supplement.